Metreleptin

Status:: Red
Decision Date:: March 2021

Comments

RED^{8 :}NICE HST14 - Metreleptin for treating lipodystrophy.

Red Drug Classifications

8. NHS England commissioned – to be used in line with NHSE commissioning intentions